U.S. Advises Older Travelers to Avoid Chikungunya Vaccine

Follow Drugslib on

Medically reviewed by Drugs.com.

By I. Edwards HealthDay Reporter

TUESDAY, May 13, 2025 — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.

The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued the warning late last week.

The concern focuses on the Valneva vaccine, known as Ixchiq, The Associated Press reported. Valneva is a specialty vaccine developer based in France.

Chikungunya is a tropical illness spread by mosquito bites. It causes fever and painful joints. About 100 to 200 U.S. travelers get the illness each year.

The government previously recommended the vaccine for adults traveling to areas where chikungunya may be common, including countries in Central and South America, Asia, India and Africa. The vaccine uses a weakened version of the virus.

The AP reported that a panel of CDC advisers recently learned of six seniors who developed serious heart or brain symptoms within a week of vaccination. Most had other health problems.

Officials also received reports of more than 10 similar cases in other countries.

European regulators are also investigating, AP reported.

A CDC advisory panel has now urged caution for adults aged 65 and older considering the Ixchiq vaccine.

They also recommended a second vaccine, Vimkunya by Bavarian Nordic, for people 12 and older traveling to areas with chikungunya outbreaks.

CDC officials have not yet made a final decision on the new recommendations.

Sources

  • The Associated Press, May 12, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-05-14 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords